Successful treatment of thyrotoxicosis is accompanied by a decrease in serum sclerostin levels
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-6614
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Successful treatment of thyrotoxicosis is accompanied by a decrease in serum sclerostin levels ; volume:5 ; number:1 ; day:13 ; month:11 ; year:2012 ; pages:1-3 ; date:12.2012
Thyroid research ; 5, Heft 1 (13.11.2012), 1-3, 12.2012
- Creator
-
Skowrońska-Jóźwiak, Elżbieta
Krawczyk-Rusiecka, Kinga
Lewandowski, Krzysztof C.
Adamczewski, Zbigniew
Lewiński, Andrzej
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-6614-5-14
- URN
-
urn:nbn:de:101:1-2021082907121251269607
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Skowrońska-Jóźwiak, Elżbieta
- Krawczyk-Rusiecka, Kinga
- Lewandowski, Krzysztof C.
- Adamczewski, Zbigniew
- Lewiński, Andrzej
- SpringerLink (Online service)
Other Objects (12)
Serum sclerostin levels in osteoporotic fracture patients
Effect of Vitamin D Treatment on Serum Sclerostin Level
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis
Serum sclerostin levels in renal cell carcinoma patients with bone metastases
Serum sclerostin is an independent predictor of mortality in hemodialysis patients
Serum level of sclerostin and vitamin D in children with epilepsy
Serum sclerostin and sympathetic skin response: relationship with myeloma bone disease
Sclerostin and Cardiovascular Disease
Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis
How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits
Serum sclerostin levels in osteoporotic fracture patients
Effect of Vitamin D Treatment on Serum Sclerostin Level
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis
Serum sclerostin levels in renal cell carcinoma patients with bone metastases
Serum sclerostin is an independent predictor of mortality in hemodialysis patients
Serum level of sclerostin and vitamin D in children with epilepsy
Serum sclerostin and sympathetic skin response: relationship with myeloma bone disease
Sclerostin and Cardiovascular Disease
Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis
How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits
Serum sclerostin levels in osteoporotic fracture patients
Effect of Vitamin D Treatment on Serum Sclerostin Level
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis
Serum sclerostin levels in renal cell carcinoma patients with bone metastases
Serum sclerostin is an independent predictor of mortality in hemodialysis patients
Serum level of sclerostin and vitamin D in children with epilepsy
Serum sclerostin and sympathetic skin response: relationship with myeloma bone disease
Sclerostin and Cardiovascular Disease
Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis